FibroBiologics, Inc. Common Stock (FBLG)
Healthcare
Biotechnology
0.79 $
+12.9%
vs. previous close
Closing price · As of: 3. Aug 2026
FibroBiologics, Inc. Common Stock (FBLG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -3.3 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.1 | -1.6 | -4.3 | -1.9 | -2.6 | -3.1 | -5.3 | -4.0 | -4.0 | -3.2 | -4.4 | -3.3 | -15 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.9 | |
| 0.4 | 0.4 | 0.5 | 0.6 | 0.6 | 0.5 | 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 2.8 | |
| 0.5 | 0.3 | 0.4 | 0.5 | 0.0 | -0.3 | -1.6 | -0.5 | 0.1 | -1.3 | -0.2 | 0.2 | -1.3 | |
| 0.4 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -0.4 | 0.0 | 0.0 | -0.1 | 0.0 | -0.1 | 0.0 | -0.2 | 0.0 | – | – | – | – | |
| – | – | – | – | -0.2 | 9.3 | 0.0 | 4.4 | 0.0 | -3.4 | 0.2 | – | – | |
| 0.9 | 0.0 | 3.3 | -0.2 | 4.5 | 9.3 | 0.0 | 4.4 | 0.0 | 3.2 | 1.0 | 5.3 | 9.5 | |
| -0.6 | -1.6 | -1.0 | -2.2 | 1.9 | 6.2 | -5.3 | 0.2 | -4.0 | 0.0 | -3.4 | 2.0 | -5.3 | |
| -1.6 | -1.6 | -4.3 | -2.0 | -2.6 | -3.2 | -5.3 | -4.2 | -4.0 | -3.2 | -4.4 | -3.3 | -15 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.